相关实验视频
Updated: Sep 13, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
病中的RNA疗法:前景和当前状态
Francesco Paolo Schena1,2, Emanuela Pasculli2,3
1Department of Emergency and Organ Transplantation, University of Bari "Aldo Moro", Bari, Italy.
基于RNA的疗法在罕见的脏疾病和先天性疾病方面表现有前途. 已批准或正在审查的RNA药物,包括microRNA,短干扰RNA和反感性寡核酸,正在对各种疾病进行评估.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 基于RNA的疗法为罕见和先天性疾病提供了新的治疗策略.
- 脏干扰是许多此类疾病的一个重要方面.
- 输送车辆对于目标RNA分子的输送至关重要.
研究的目的:
- 审查目前关于基于RNA治疗脏相关的罕见和先天性疾病的知识.
- 专注于监管机构 (FDA/EMA) 批准或正在审查的药物.
- 探索微RNA,短干扰RNA和反意义寡核酸的治疗潜力.
主要方法:
- 现有文献和药物批准状态的叙述性审查.
- 鉴定针对特定病的基于RNA的药物.
- 临床试验数据和正在进行的评估的摘要.
主要成果:
- 微RNA (miRNA) 显示出阿尔波特综合征,多囊性病和细胞癌的潜力.
- 短干扰RNA (siRNA) 被评估为原发性高氧化尿,遗传性转基因氨基粉症,急性损伤和高胆固醇血症.
- 反感性寡核酸是有效的高胆固醇高血症与他类药物的副作用和氨基粉症.
结论:
- 基于RNA的疗法代表了罕见脏和先天性疾病的前沿.
- 进一步的大规模临床试验对于验证这些治疗方法至关重要.
- 这些方法也正在探索常见的病原因,如高血压和糖尿病.
更多相关视频
07:01Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
Published on: May 10, 2022
06:38Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
相关概念视频
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Kidney Transplant I: Introduction
Renal Drug Excretion: Overview
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Chronic Kidney Disease I: Introduction